Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of LUMAKRAS with half circle design over KRAS.
PIXEL COUNT ACCEPTABLE
YES
PIXEL COUNT
643 x 259
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Amgen Inc,
INTERNAL ADDRESS
Trademark Operations - MS-28-5A
*MAILING ADDRESS
One Amgen Center Drive
*CITY
Thousand Oaks
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
91320-1799
PHONE
805-447-3278
*EMAIL ADDRESS
XXXX
WEBSITE ADDRESS
www.amgen.com
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical preparations for use in the prevention of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune
diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and
disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders;
pharmaceutical preparations for use in the treatment of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for
use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Elsa D. Lemoine
ATTORNEY DOCKET NUMBER
TM-2135-US-1
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Amgen Inc.
INTERNAL ADDRESS
Trademark Operations-MS-28-5A
STREET
One Amgen Center Drive
CITY
Thousand Oaks
STATE
California
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
91320-1799
PHONE
805-447-3278
EMAIL ADDRESS
elemoine@amgen.com
OTHER APPOINTED ATTORNEY
Timothy J. Gaul, Richard V. Person, and Stuart L. Watt
CORRESPONDENCE INFORMATION
NAME
Elsa D. Lemoine
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
elemoine@amgen.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
tmops@amgen.com
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
1
APPLICATION FOR REGISTRATION PER CLASS
350
*TOTAL FEES DUE
350
*TOTAL FEES PAID
350
SIGNATURE INFORMATION
SIGNATURE
/Elsa D. Lemoine/
SIGNATORY'S NAME
Lemoine, Elsa D.
SIGNATORY'S POSITION
Attorney of Record, California Bar member
SIGNATORY'S PHONE NUMBER
805-447-3278
DATE SIGNED
02/17/2021
SIGNATURE METHOD
Sent to third party for signature
PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:90532537
Filing Date:02/17/2021
To the Commissioner for Trademarks:
MARK: LUMAKRAS (stylized and/or with design, see mark)
The literal element of the mark consists of LUMAKRAS. The applicant is not claiming color as a feature of the mark. The mark consists of LUMAKRAS with half circle design over KRAS.
The applicant, Amgen Inc,, a corporation of Delaware, having an address of
Trademark Operations - MS-28-5A
One Amgen Center Drive
Thousand Oaks, California 91320-1799
United States
805-447-3278(phone)
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical preparations for use in the prevention of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders;
pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone,
joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; pharmaceutical preparations for use
in the treatment of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors
and growths, hemolytic diseases and disorders, amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
For informational purposes only, applicant's website address is: www.amgen.com
The owner's/holder's proposed attorney information: Elsa D. Lemoine. Other appointed attorneys are Timothy J. Gaul, Richard V. Person, and Stuart L. Watt. Elsa D. Lemoine of Amgen Inc., is a
member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
Trademark Operations-MS-28-5A
One Amgen Center Drive
Thousand Oaks, California 91320-1799
United States
805-447-3278(phone)
elemoine@amgen.com
The docket/reference number is TM-2135-US-1.
Elsa D. Lemoine submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Elsa D. Lemoine/ Date: 02/17/2021
Signatory's Name: Lemoine, Elsa D.
Signatory's Position: Attorney of Record, California Bar member
Signatory's Phone Number: 805-447-3278
Signature method: Sent to third party for signature
Payment Sale Number: 90532537
Payment Accounting Date: 02/17/2021
Serial Number: 90532537
Internet Transmission Date: Wed Feb 17 16:29:12 ET 2021
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.X-2021021716291245
2345-90532537-770185067fd5acf0c0e3397a23
1768e183203bd2cb65f868b1bcd7b930add39-DA
-29123686-20210217122650324630